Is CBMX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

551 people get CBMX articles and Market Currents by email alert.

Get email alerts on CBMX »

HEADLINES:

CombiMatrix Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8 • 1 Comment
CombiMatrix Corporation Reports Results for 2013 First Quarter

GlobeNewswire (May 8, 2013)
CombiMatrix Executes Equity Financing

GlobeNewswire (May 6, 2013)
CombiMatrix Corporation to Release First Quarter Financial Results on May 8, 2013

GlobeNewswire (May 1, 2013)
CombiMatrix Reports Preliminary Quarterly Growth in Prenatal Testing Volumes of 124% for First Quarter

GlobeNewswire (Apr 4, 2013)
CombiMatrix Announces $2 Million Registered Direct Offering

GlobeNewswire (Mar 20, 2013)
CombiMatrix Potential Turnaround
Tomas Leszczynski • Mon, Mar 18 • 5 Comments
CombiMatrix Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 27
CombiMatrix Corporation Reports Results for 2012 Fourth Quarter

GlobeNewswire (Feb 27, 2013)
Mark McDonough to Assume CEO Role at CombiMatrix

GlobeNewswire (Feb 22, 2013)
Why CombiMatrix Shares Will Double By The End Of The Month
Biotech Breakthroughs • Thu, Feb 21 • 51 Comments
CombiMatrix Corporation to Release Fourth Quarter and Year-End Financial Results on February 27, 2013

GlobeNewswire (Feb 20, 2013)
CombiMatrix Reports Preliminary Annual Growth in Prenatal Testing Volumes of 172% and 171% for Fourth Quarter and Year, Respectively

GlobeNewswire (Jan 7, 2013)
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

GlobeNewswire (Dec 20, 2012)
Thoughts On 3 Of The Craziest Low-Float Stocks
StockBaller • Wed, Dec 12, 2012 • 3 Comments
CombiMatrix Skyrockets After Important Medical Publication
Brian L. Wilson • Tue, Dec 11, 2012 • 1 Comment
Biotech Weekly Recap: The Market Holds While Biotech Crumbles
Brian L. Wilson • Sun, Dec 9, 2012 • 6 Comments
NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis

GlobeNewswire (Dec 7, 2012)
CombiMatrix Stockholders Approve Second Tranche of Series A Preferred Stock Financing; Announces 1-for-10 Reverse Split of Common Stock and Nasdaq-Listed Warrants

GlobeNewswire (Dec 4, 2012)
CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

GlobeNewswire (Nov 28, 2012)

To learn more about Seeking Alpha Pro, click here.

CombiMatrix Potential Turnaround
Tomas Leszczynski • Mon, Mar 18 • 5 Comments
Why CombiMatrix Shares Will Double By The End Of The Month
Biotech Breakthroughs • Thu, Feb 21 • 51 Comments
CombiMatrix Skyrockets After Important Medical Publication
Brian L. Wilson • Tue, Dec 11, 2012 • 1 Comment
CombiMatrix: Full Array of Pending Catalysts
Mike Havrilla • Wed, Sep 2, 2009 • 7 Comments
More Than a Few Reasons to Buy CombiMatrix
Mike Havrilla • Fri, Mar 13, 2009 • 2 Comments

Thoughts On 3 Of The Craziest Low-Float Stocks
StockBaller • Wed, Dec 12, 2012 • 3 Comments
Biotech Weekly Recap: The Market Holds While Biotech Crumbles
Brian L. Wilson • Sun, Dec 9, 2012 • 6 Comments
Tracking Cancer Diagnostic and Therapeutic Stocks
Mike Havrilla • Mon, Apr 13, 2009 • 6 Comments
Winning Stocks in the Age of Personalized Medicine
John Putnam • Wed, Mar 4, 2009
Healthcare Reform, M&A Likely to Focus on Preventative Medicine
Mike Havrilla • Mon, Jan 26, 2009 • 2 Comments
Create Your Own Diagnostics ETF
Mike Havrilla • Wed, Jan 21, 2009 • 3 Comments
CombiMatrix and Clarient Partner to Market a More Sophisticated Cancer Test
Douglas Cress • Tue, Feb 5, 2008

CombiMatrix Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8 • 1 Comment
CombiMatrix Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 27

CombiMatrix Corporation Reports Results for 2013 First Quarter

GlobeNewswire (May 8, 2013)
CombiMatrix Executes Equity Financing

GlobeNewswire (May 6, 2013)
CombiMatrix Corporation to Release First Quarter Financial Results on May 8, 2013

GlobeNewswire (May 1, 2013)
CombiMatrix Reports Preliminary Quarterly Growth in Prenatal Testing Volumes of 124% for First Quarter

GlobeNewswire (Apr 4, 2013)
CombiMatrix Announces $2 Million Registered Direct Offering

GlobeNewswire (Mar 20, 2013)
CombiMatrix Corporation Reports Results for 2012 Fourth Quarter

GlobeNewswire (Feb 27, 2013)
Mark McDonough to Assume CEO Role at CombiMatrix

GlobeNewswire (Feb 22, 2013)
CombiMatrix Corporation to Release Fourth Quarter and Year-End Financial Results on February 27, 2013

GlobeNewswire (Feb 20, 2013)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 7, 2013)
CombiMatrix Reports Preliminary Annual Growth in Prenatal Testing Volumes of 172% and 171% for Fourth Quarter and Year, Respectively

GlobeNewswire (Jan 7, 2013)
CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

GlobeNewswire (Dec 20, 2012)
NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis

GlobeNewswire (Dec 7, 2012)
CombiMatrix Stockholders Approve Second Tranche of Series A Preferred Stock Financing; Announces 1-for-10 Reverse Split of Common Stock and Nasdaq-Listed Warrants

GlobeNewswire (Dec 4, 2012)
CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

GlobeNewswire (Nov 28, 2012)
CombiMatrix Appoints Jeremy M. Jones to Board of Directors

GlobeNewswire (Nov 26, 2012)
CombiMatrix Corporation Reports Results for 2012 Third Quarter

GlobeNewswire (Nov 7, 2012)
CombiMatrix and Pathology, Inc. Form Partnership to Market and Distribute Prenatal Tests

GlobeNewswire (Nov 6, 2012)
CombiMatrix Corporation to Release Third Quarter and Nine-Month Financial Results on November 7, 2012

GlobeNewswire (Oct 31, 2012)
CombiMatrix Executes Equity Financing

GlobeNewswire (Oct 1, 2012)
CombiMatrix Names Mark McDonough Chief Commercial Officer

GlobeNewswire (Aug 23, 2012)

CBMX vs. ETF Alternatives

Company Description

Currently, there's no company description for CBMX.

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Monday, May 6, 9:12 AM Premarket gainers: CBMX +8%. YRCW +7%. APO +7%. CTIC +6%.
Losers: PAL -12%. LNCO -7%. LINE -6%. 12 Comments [On the Move]
Monday, May 6, 8:50 AM CombiMatrix (CBMX) +11.8% premarket after announcing a private placement of $2.4M in Series C convertible preferred shares (conversion price $3.05, warrants to purchase 125% of underlying with conversion price of $3.77). Proceeds will be received in two tranches of $1.2M each. (PR) Comment! [Healthcare, On the Move]
Friday, April 5, 9:10 AM Premarket gainers: XIDE +31%. NIHD +10%. NVAX +5%.
Losers: RIGL -36%. FFIV -18%. RDWR -18%. JNPR -7%. CBMX -5%. Comment! [On the Move]
Thursday, April 4, 9:19 AM CombiMatrix (CBMX) +19.6% premarket after reporting billable prenatal testing volumes rose 127% in Q1 from a year earlier, and the genetic-based testing company says it plans to expand its offerings to capture share in the rapidly growing market. Overall billable testing volumes rose 25% Y/Y. Comment! [Healthcare, On the Move]
Thursday, April 4, 9:10 AM Premarket gainers: CBMX +20%. PSDV +13%. NAVB +10%. ALU +9%. ARIA +6%.
Comment! [On the Move]
Tuesday, March 12, 12:50 PM Midday top 10 gainers: BOSC +23%. EMITF +19%. OCZ +18%. CLIR +17%. XNY +16%. CIS +14%. GLUU +13%. TLF +12%. ENPH +12%. CAB +12%.
Midday top 10 losers: RVP -15%. FREE -14%. EMAN -13%. LAKE -13%. CBMX -13%. SHOS -12%. CALI -11%. AVG -11%. SLCA -10%. HIMX -10%. Comment! [On the Move]
Tuesday, March 12, 9:32 AM CombiMatrix (CBMX -7.2%) receives a notice from Nasdaq saying that because it has stockholder's equity of -$1.12M, it is no longer in compliance with the exchange's requirement for stockholder equity of +$2.5M. CombiMatrix has until April 25 to present a plan to return to compliance, at which point Nasdaq can grant the company a grace period to carry out the plan or reject it and recommend that CombiMatrix be delisted. (PR) Comment! [Healthcare, On the Move]
Tuesday, March 12, 9:10 AM Premarket gainers: GLUU +23%. OCZ +15%. LLEN +12%. HEK +9%. PAY +7%. RFIL +7%. YUM +6%.
Losers: PWRD -10%. CBMX -7%. FCEL -7%. RSH -7%. DMND -6%. YNDX -6%. CALI -6%. 1 Comment [On the Move]
Monday, March 11, 12:56 PM Midday top 10 gainers: CALI +52%. BOSC +45%. ESYS +30%. CBMX +25%. LAS +25%. PAMT +15%. FONR +15%. SCR +15%. SGOC +15%. RWC +14%.
Midday top 10 losers: AEZS -21%. NSU -11%. CSIQ -11%. SPEX -11%. FREE -10%. DKS -10%. CERE -10%. CNIT -9%. ONP -9%. RDCM -8%. Comment! [On the Move]
Friday, March 1, 1:01 PM Midday top 10 gainers: GMXR +56%. RVLT +37%. MTG +24%. ANAC +15%. DECK +14%. NSPH +13%. KERX +13%. ATEC +13%. CRIS +12%. CIDM +12%.
Midday top 10 losers: SCMR -73%. AT -29%. RNIN -23%. LTBR -23%. FWLT -17%. MDR -14%. SUP -13%. SHIP -13%. MNOV -12%. CBMX -12%. Comment! [On the Move]
Wednesday, February 27, 2:44 PM CombiMatrix (CBMX -21%) gets slammed after reportingg Q4 revenue that was up 18% Y/Y on higher revenues from its core prenatal testing markets, which grew by 161% on increased billable test volumes. However, net losses soared on non-cash warrant derivative charges as a result of issuing warrants to certain investors in the Company's Series A Preferred Stock financing. 2 Comments [Healthcare, On the Move, Earnings]
Wednesday, February 27, 12:55 PM Midday top 10 gainers: ZGNX +39%. UNXL +24%. FSGI +21%. GWRE +18%. ELMD +16%. PDCE +14%. OPTR +13%. DLTR +12%. END +11%. SHI +11%.
Midday top 10 losers: AH -26%. CBB -23%. AMBO -22%. RNIN -21%. CBMX -19%. XWES -19%. FSLR -16%. CMGE -15%. CRMB -13%. PRPH -12%. Comment! [On the Move]
Wednesday, February 27, 6:14 AM CombiMatrix (CBMX): Q4 EPS of -$3.31. Revenue of $1.5M (+18% Y/Y). (PR) Comment! [Earnings, Breaking News, Tech]
Friday, February 22, 12:53 PM Midday top 10 gainers: WBMD +25%. EDAP +24%. PSDV +24%. ARUN +22%. BLOX +17%. SSTK +16%. FIRE +15%. B +15%. AVG +12%. RKUS +12%.
Midday top 10 losers: ETRM -20%. MMSI -19%. WIFI -18%. FRO -14%. NVGN -12%. CBMX -12%. VOLC -11%. GMXR -16%. RCKY -11%. REED -11%. Comment! [On the Move]
Friday, February 22, 11:05 AM CombiMatrix (CBMX -16.8%) gives back a little bit of its huge gain from yesterday, after announcing that Mark McDonough, currently the company's Chief Commercial Officer, will become CEO following the retirement of CEO R. Judd Jessup, who has announced he will be stepping down effective March 15, 2013. Comment! [On the Move, Healthcare]
Thursday, February 21, 2:49 PM CombiMatrix (CBMX) soars 140% after SA author Biotech Breakthroughs says investors have forgotten about management's fantastic early-year guidance and allowed the stock to drift down. With the earnings report and conference call imminent, they're about to get reminded. The stock's a double by the end of the month. Target hit. Comment! [Healthcare, On the Move]

coshalcobra
pop forthcoming after $CBMX posts great finan results, load up folks!
May 6, 8:28 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ubillu
$CBMX--Appears that the market in later trading is discounting the news and the bloom has faded. Perkins Cove had this days trading nailed.
Apr 4, 3:29 PM
Reply (1)

• !Report Abuse
View all 1 replies
Perkins Cove: Thanks ubillu. Kudos to SA for bringing $CBMX to my attention via Market Currents in time to act on it, even if they typed "CMBX"....grin
Apr 4, 3:40 PM
• !Report Abuse
Add a reply...

140 characters

ubillu
$CBMX, long trading pause at $4.10--looks like a downward move coming.
Apr 4, 1:15 PM
Reply (2)

• !Report Abuse
View all 2 replies
Perkins Cove: The perfect play for today was to buy @4.05 in pre and sell @4.60 around 9:45am. (now @ $3.90ish) "The Quick & The Dead"......grin
Apr 4, 1:33 PM
• !Report Abuse
Perkins Cove: Such is the life of Biotechs.....
Apr 4, 1:35 PM
• !Report Abuse
Add a reply...

140 characters

Perkins Cove
$CBMX, sell @ $4.43 for a 6.24% portfolio gain. Getting up from the table, hit my $ target.
Apr 4, 9:35 AM
Reply (28)

• !Report Abuse
View all 28 replies
det9: Also bought $SN @ 18.47, $BX @ 19.03, $INTC @ 19.80
Apr 6, 5:42 PM
• !Report Abuse
Ocean Man: Buying the dip on $BX yesterday was rewarded.
Apr 6, 11:23 PM
• !Report Abuse
Add a reply...

140 characters

Perkins Cove
$CBMX, buy @4.17 in pre mkt, daytrade.....http://seekingalpha.com/n/jtxp
Apr 4, 9:20 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
$CBMX - A Classic Twitter Newsletter Pump http://bit.ly/YdWCku
Feb 21, 3:46 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

equivalent
$CBMX why does it keep dropping with such good news about tests?
Feb 13, 4:17 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

timtrading
$CBMX - up 23% today http://bit.ly/13bi4sv
Jan 7, 9:56 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

timtrading
What do you think of $CBMX? http://bit.ly/TrGRU6
12/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
Evening Tape: $CBMX Soars, Banks Run, & New Uptrend Rating $SPY http://bit.ly/YLAJvE
12/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Perkins Cove
$CBMX, sell @ $4.43 for a 6.24% portfolio gain. Getting up from the table, hit my $ target.
Apr 4, 9:35 AM
Reply (28)

• !Report Abuse
View all 28 replies
det9: Also bought $SN @ 18.47, $BX @ 19.03, $INTC @ 19.80
Apr 6, 5:42 PM
• !Report Abuse
Ocean Man: Buying the dip on $BX yesterday was rewarded.
Apr 6, 11:23 PM
• !Report Abuse
Add a reply...

140 characters

ubillu
$CBMX--Appears that the market in later trading is discounting the news and the bloom has faded. Perkins Cove had this days trading nailed.
Apr 4, 3:29 PM
Reply (1)

• !Report Abuse
View all 1 replies
Perkins Cove: Thanks ubillu. Kudos to SA for bringing $CBMX to my attention via Market Currents in time to act on it, even if they typed "CMBX"....grin
Apr 4, 3:40 PM
• !Report Abuse
Add a reply...

140 characters

ubillu
$CBMX, long trading pause at $4.10--looks like a downward move coming.
Apr 4, 1:15 PM
Reply (2)

• !Report Abuse
View all 2 replies
Perkins Cove: The perfect play for today was to buy @4.05 in pre and sell @4.60 around 9:45am. (now @ $3.90ish) "The Quick & The Dead"......grin
Apr 4, 1:33 PM
• !Report Abuse
Perkins Cove: Such is the life of Biotechs.....
Apr 4, 1:35 PM
• !Report Abuse
Add a reply...

140 characters

CBMX CombiMatrix Corporation

CBMX

CombiMatrix Corporation